The interplay between slow-cycling, chemoresistant cancer cells and fibroblasts creates a proinflammatory niche for tumor progression

Journal: Cancer Research

Published: 2020-06-01

DOI: 10.1158/0008-5472.can-19-0631

Affiliations: 9

Authors: 15

Go to article
Institutions Share
Seoul National University (SNU), South Korea 0.60
Inje University, South Korea 0.13
JEUK Co., Ltd., South Korea 0.13
Asan Medical Center (AMC), South Korea 0.07
Yonsei University Health System (YUHS), South Korea 0.03
Severance Hospital, Yonsei University, South Korea 0.03